Abstract Background/Introduction Females presenting with ST-segment elevation myocardial infarction (STEMI) are characterized by an increased risk of bleeding after primary percutaneous coronary intervention (pPCI) compared males. The reason for rates is multifactorial, including age, comorbidities, vessel anatomy and possible differences in platelet biology. Data about reactivity levels female...

Abstract Introduction Dual antiplatelet therapy represents the standard of care for treatment patients with acute coronary syndrome (ACS). Ticagrelor is a direct-acting P2Y12 inhibitor and does not require metabolic activation. Objective To assess whether chewed 180 mg ticagrelor loading dose (LD), compared to conventional oral administration, increases platelet inhibition reduces high on-treat...